CLARI — Clariane SE Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapTurnaround

Annual income statement for Clariane SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,773	4,137	4,438	4,996	5,282
Cost of Revenue
Gross Profit	3,476	3,828	4,086	4,592	4,843
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,507	3,796	4,166	4,832	5,020
Operating Profit	266	342	273	163	262
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	60.1	133	57.9	-76.2	-36.7
Provision for Income Taxes
Net Income After Taxes	42.9	122	45.8	-73.6	-27.3
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	39.4	91.1	22.1	-105	-55.1
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	39.4	91.1	22.1	-105	-55.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.258	0.797	0.438	0.038	-0.06
Dividends per Share